Invention Application
US20100144751A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
审中-公开
咪唑并[1,2-a]吡啶化合物作为受体酪氨酸激酶抑制剂
![IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS](/docs/US/2010-06-10/US20100144751A1/abs.jpg.600x600.jpg)
- Patent Title: IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
- Patent Title (中): 咪唑并[1,2-a]吡啶化合物作为受体酪氨酸激酶抑制剂
-
Application No.: US12593041Application Date: 2008-03-27
-
Publication No.: US20100144751A1Publication Date: 2010-06-10
- Inventor: Fredrik P. Marmsater , Mark C. Munson , James P. Rizzi , John E. Robinson , Stephen T. Schlacter , George T. Topalov , Joseph P. Lyssikatos
- Applicant: Fredrik P. Marmsater , Mark C. Munson , James P. Rizzi , John E. Robinson , Stephen T. Schlacter , George T. Topalov , Joseph P. Lyssikatos
- Applicant Address: US CO Boulder
- Assignee: ARRAY BIOPHARMA INC.
- Current Assignee: ARRAY BIOPHARMA INC.
- Current Assignee Address: US CO Boulder
- International Application: PCT/US08/58385 WO 20080327
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D471/04 ; A61K31/4709 ; A61P35/00
![IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS](/abs-image/US/2010/06/10/US20100144751A1/abs.jpg.150x150.jpg)
Abstract:
Compounds of Formula (I): are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class (3) and class (5) receptor tyrosine kinases. Particular compounds of this invention have also been found to be inhibitors of Pim-1.
Information query
IPC分类:
